| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.48 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |